Promoting the Calcium-Uptake Bioactivity of Casein Phosphopeptides in vitro and in vivo

• Published in: Frontiers in nutrition (Lausanne) 2021-08, Vol.8, p.743791-743791
• Main Authors: Liu, Guo, Guo, Baoyan, Sun, Shengwei, Luo, Minna, Liu, Fei, Miao, Jianyin, Tang, Jian, Huang, Yahui, Cao, Yong, Song, Mingyue
• Format: Article
• Language: English
• Subjects: animal model; Caco-2; calcium binding capacity; calcium uptake bioactivities; casein phosphopeptides; Nutrition
• ISSN: 2296-861X; 2296-861X
• DOI: 10.3389/fnut.2021.743791

Casein phosphopeptides have been studied widely for their ability to chelate calcium. However, systematic studies on the effects of casein phosphopeptides (CPP) on calcium absorption in vitro and in vivo are scarce. The purities of two commercially available products, CPP1 and CPP2, are 18.37 and 25.12%, respectively. Here, the in vitro calcium binding capacity of CPP2 was 142.56 ± 7.39 mg/g, which was higher than that of CPP1 (107.15 ± 6.27 mg/g). The calcium transport results in a Caco-2 monolayer model indicated that, relative to controls, CPP1 and CPP2 increased calcium transport by 21.78 and 53.68%, respectively. Subsequent animal experiments showed that the CPP2-Ca-H group (1% Ca, 0.4% CPP2) had significant increases in the femur index, serum Ca 2+ and serum osteocalcin levels, and femoral Ca content. The CPP2-Ca-H animal also had decreased serum alkaline phosphatase levels, parathyroid hormone content, and urinary pyridinoline content. Overall, our results demonstrated that CPP2 had stronger effects on promoting calcium uptake than CPP1.